RCL
74
5
CA
19
6
BK
60
2
AIZ
61
5
IR
46
3
FAST
41
7
NRG
32
5
MCO
67
3
T
32
2
MAS
46
3
MU
42
14
DD
44
2
SNA
56
3
BIIB
36
8
PFE
37
4
BLK
46
2
NVDA
52
5
MHK
25
5
RRC
52
2
NTRS
35
10
RCL
74
5
CA
19
6
BK
60
2
AIZ
61
5
IR
46
3
FAST
41
7
NRG
32
5
MCO
67
3
T
32
2
MAS
46
3
MU
42
14
DD
44
2
SNA
56
3
BIIB
36
8
PFE
37
4
BLK
46
2
NVDA
52
5
MHK
25
5
RRC
52
2
NTRS
35
10
Financhill
Back

HCA Healthcare 10K Form

Sell
37

HCA
HCA Healthcare

Last Price:
$303.44
Seasonality Move:
8.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HCA News And Ratings

See the #1 stock for the next 7 days that we like better than HCA

HCA Financial Statistics

Sales & Book Value

Annual Sales: $65B
Cash Flow: $2.3B
Price / Cash Flow: 13.72
Annual Sales: $-8.57
Price / Book: 0

Profitability

EPS (TTM): 22.27000
Net Income (TTM): $5.9B
Gross Margin: $55.1B
Return on Equity: 616.06%
Return on Assets: 10.42%

HCA Healthcare Earnings Forecast

Key HCA Healthcare Financial Ratios

  • The Gross Profit Margin over the past 34 years for HCA is 84.76%.
  • The Selling, General & Administrative Expenses for HCA have been equal to 45.39% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 36.97% of Operating Income.
  • The Net Earning history of HCA is 8.07% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 19 years.

HCA Healthcare Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: HCA
CUSIP: 40412C
Website: hcahealthcare.com

Debt

Debt-to-Equity Ratio: -19.69
Current Ratio: 1.12
Quick Ratio: 0.86

Price-to-Earnings

Trailing P/E Ratio: 16.01
Forward P/E Ratio: 12.33

HCA Technical Analysis vs Fundamental Analysis

Sell
37
HCA Healthcare (HCA) is a Sell

Is HCA Healthcare a Buy or a Sell?

  • HCA Healthcare stock is rated a Sell
    The current HCA Healthcare [HCA] share price is $303.62. The Score for HCA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.